Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in Africans
Open Access
- 12 August 2024
- journal article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 18 (6) , e1002-e1014
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Beyond fibrinolysis: The confounding role of Lp(a) in thrombosisAtherosclerosis, 2022
- Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe aortic stenosisAtherosclerosis, 2022
- The clinical utility of apoB versus LDL-C/non-HDL-CClinica Chimica Acta, 2020
- Apolipoprotein B Particles and Cardiovascular DiseaseJAMA Cardiology, 2019
- Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a): Findings from a randomized controlled cross-over trialJournal of Clinical Lipidology, 2019
- Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot propertiesJournal of Thrombosis and Thrombolysis, 2018
- Weight loss is a critical factor to reduce inflammationClinical Nutrition ESPEN, 2018
- The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levelsBlood Reviews, 2016
- The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countriesAmerican Heart Journal, 2009
- Effects of low-density lipoproteins on blood coagulation and fibrinolytic activity.Bulletin of Experimental Biology and Medicine, 2000